Kadmos Capital

Entity category: ORGANIZATION

AI & Tech

Antiverse Secures $9.3M to Scale AI-Powered Antibody Discovery

March 3, 2026
Two men in suits stand smiling on a staircase.

Antiverse, a Cardiff-based biotech firm, has secured a $9.3 million Series A investment to scale its AI-driven drug discovery platform…

Read More »